Planning for Long-Term GLP-1 Use Ongoing communication with a healthcare provider is essential to evaluate long-term options
These additives have no proven clinical benefit for patients taking tirzepatide, and the resulting combinations introduce unknown risks for patients
El Asmar builds a tailored plan that integrates tirzepatide injections with dietary guidance, lifestyle recommendations, and ongoing progress assessments
18 The SYNERGY-NASH (A Study of Tirzepatide [LY3298176] in Participants With Nonalcoholic Steatohepatitis) trial, 19 a phase 2b dose-finding study, randomized 190 patients with biopsy-confirmed MASH and stage 2 or 3 fibrosis to receive weekly injections of the GLP-1 and GIP dual agonist tirzepatide 5 mg, 10 mg, or 15 mg or placebo for 52 weeks
How to choose the right concentration for your protocol The best concentration depends on where you are in your dosing schedule
A true Mounjaro allergic reaction is less common and may cause hives, widespread itchy skin, or a Mounjaro skin reaction that spreads beyond the injection site
